| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10755775 | Biochemical and Biophysical Research Communications | 2014 | 8 Pages |
Abstract
Taken together, these data suggest that anti-miR-197 suppresses HCC migration and invasion by targeting CD82. The regulation of the miR-197/CD82 axis could be a novel therapeutic target in future HCC effective therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Weiqi Dai, Chengfen Wang, Fan Wang, Yugang Wang, Miao Shen, Kan Chen, Ping Cheng, Yan Zhang, Jing Yang, Rong Zhu, Huawei Zhang, Jingjing Li, Yuanyuan Zheng, Jie Lu, Yingqun Zhou, Ling Xu, Chuanyong Guo,